Biosysen Limited, a Cayman Islands–incorporated company formerly known as Legend Strategy International Holdings Group Company Limited, released a bilingual circular on 5 August 2026 detailing a proposal to increase its authorised share capital.

The circular, now available on both the company’s website (www.biosysen.bio) and the Hong Kong Stock Exchange’s website (www.hkexnews.hk), also serves as the formal notice of an Extraordinary General Meeting scheduled for 25 August 2026. Shareholders will vote on the capital-increase proposal at that meeting.

Non-registered shareholders—those whose Biosysen shares are held through the Central Clearing and Settlement System (CCASS)—are being notified of their options to access the documents. While the circular and related corporate communications are posted online, printed copies can be obtained free of charge upon written or email request to the company’s Hong Kong share registrar, Union Registrars Limited.

Investors holding shares via intermediaries such as banks, brokers, custodians or HKSCC Nominees Limited may opt to receive future corporate communications electronically by providing a functional email address through their intermediaries. Failure to supply an email address will result in continued reliance on web-based publication notices.

Enquiries regarding the notification or requests for hard-copy materials can be directed to Union Registrars Limited at +852 2849 3399 during business hours (Monday–Friday, 9:00 a.m.–5:00 p.m., excluding public holidays).